mmegi

Bomaid in talks for MRI’s 45% stake

In charge: Bomaid CEO, Mokgosana PIC: PHATSIMO KAPENG
In charge: Bomaid CEO, Mokgosana PIC: PHATSIMO KAPENG

Botswana Medical Aid Society (Bomaid), a leading private medical aid provider, is currently in talks with a potential investor willing to buy a stake in its subsidiary, MRI. Bomaid CEO, Moraki Mokgosana told BusinessWeek that talks are currently at an advanced stage with the potential investor.

“Yes, this is true. BOMAID is currently in talks with a potential investor. However, due to the sensitive nature of such discussions and a binding non-disclosure agreement signed by the two parties we are not at a point to disclose any further information at this point,” he said.

Bomaid currently holds 94% shareholding in its subsidiary MRI and seeks to divest 45% of its shares. MRI operates clinics, pharmacies, and emergency-response services throughout the country accessible by Bomaid and other medical aid societies.

Editor's Comment
‘Fake’ drugs: A matter of life, truth and accountability

When claims of such gravity are made, especially by a sitting Assistant Minister they cannot be brushed aside, delayed, or treated as routine political noise. Even the Ombudsman has confirmed receipt of a report from a political party and a review of these complaints is now underway. That is a necessary first step. But it is only the beginning. The seriousness of the allegations demands urgency, transparency and clarity. The public is entitled to...

Have a Story? Send Us a tip
arrow up